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OBJECTIVE: The aim of this study was to investigate the correlation between the immunoglobulin A immune
response to Gardnerella vaginalis hemolysin and sialidase activity in vaginal fluids from patients with bacter-
ial vaginosis.
STUDY DESIGN: Nonpregnant women who were examined at a gynecologic clinic, in an age range of 18 to
62 years, were enrolled. The study population comprised 131 healthy volunteers, 32 women with bacterial
vaginosis that was positive for immunoglobulin A to Gardnerella vaginalis hemolysin, 40 women with bacter-
ial vaginosis that was negative for immunoglobulin A to Gardnerella vaginalis hemolysin, and 19 women with
Candida vaginitis. Bacterial vaginosis was diagnosed by clinical criteria and Gram stain.
RESULTS: Sialidase activity was present in 75% (54/72) of patients with bacterial vaginosis. Women having
bacterial vaginosis and lacking a specific immunoglobulin A response had a significantly higher level of siali-
dase activity than patients who had an immune response against Gardnerella vaginalis hemolysin. Sialidase
activity was detected in 87% (35/40) of the former subgroup of patients with bacterial vaginosis and in 59%
(19/32) of women of the latter subgroup. No sialidase activity was measured in patients with candidiasis.
Specificity of the assay for healthy controls was 95% (124/131 women without sialidase activity).
CONCLUSIONS: Sialidases produced by Prevotella bivia and other microorganisms present in the mi-
croflora of patients with bacterial vaginosis are very likely a virulence factor not only by destroying the
mucins and enhancing adherence of bacteria but also by impairing a specific immunoglobulin A immune re-
sponse against other virulence factors such as cytotoxin from Gardnerella vaginalis. (Am J Obstet Gynecol
1998;178:511-5.)
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Bacterial vaginosis is a polymicrobial syndrome charac-
terized by a complex bacterial milieu; it is the most com-
mon disorder diagnosed in women who are examined at
sexually transmitted disease clinics and is reported in
about 20% of pregnant women.1 Although bacterial vagi-
nosis is recognized as a risk factor in obstetrics and gyne-
cology,2-7 little is known about the pathogenesis and the
persistence of this syndrome.
Some bacteria involved in bacterial vaginosis are able
to produce sialidases. Sialidases, or neuraminidases, have
been implicated in the pathogenesis of many diseases;
they catalyze the removal of terminal sialic acid residues
from various glycoconjugates and play a role in bacterial
nutrition, cellular interactions, and immune response
evasion.8 Recently Briselden et al.9 demonstrated in-
creased levels of sialidase activity in vaginal wash samples
obtained from women with bacterial vaginosis. Sialidase
activity correlates mainly with the presence of high titers
of Prevotella spp. and Bacteroides spp.9, 10 Sialidase activity
in vaginal fluids of women at 8 weeks after topical treat-
ment with clindamycin was found to correlate with an in-
creased risk of preterm birth and low birth weight by
McGregor et al.11
From previous investigations we determined the
biophysical properties of the hemolysin released by
G. vaginalis.12, 13 G. vaginalis hemolysin is a pore-
forming, cholesterol-binding cytolysin, which has maxi-
mal cytotoxic activity in physiologic conditions at the pH
values of the vaginal secretions and is the sole identified
and characterized virulence determinant of G. vaginalis.
About half of the women with bacterial vaginosis show an
anti–G. vaginalis toxin immunoglobulin A response.14
The two subgroups of bacterial vaginosis patients
(anti–G. vaginalis toxin IgA positive and negative) are in-
distinguishable by normal criteria used to diagnose bac-
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terial vaginosis. The aim of the current study was to assay
vaginal fluid for the presence of the specific immune re-
sponse against the toxin produced by G. vaginalis and
evaluate the correlation of this parameter with the siali-
dase activity to determine whether the extracellular mu-
colytic enzymes are involved in a modulation of the host
immune response.
Material and methods
Subjects and vaginal washings. Participants were re-
cruited among women seeking care at the gynecologic
care unit of Azienda per i Servizi Sanitari Medio Friuli,
Udine, Italy. All patients were interviewed and examined
by one clinician. On entry to the study oral informed
consent was sought from all women, who were then in-
terviewed for medical, obstetric, sexual, and contracep-
tive historic data. Women were excluded from the study
for the use of oral or vaginal antibiotics in the past 2
weeks, pregnancy, menstruation or bleeding, sexual in-
tercourse in the last 3 days, and in the case of the healthy
control group for complaint of vaginal symptoms in the
last 2 months.
By means of a cotton swab a sample of vaginal fluid was
obtained from the lateral vaginal sidewall for evaluation
of pH (with paper strip pH range from 4.0 to 7.0) and
rolled onto two glass slides for Gram stain evaluation and
release of amine odor by the addition of 10% potassium
hydroxide (“whiff test”).
Vaginal wash specimens were prepared by inserting a
sterile, nonlubricated speculum, washing the vaginal
walls with 10 ml of sterile saline solution, and removing
the resultant suspension with a sterile syringe. The vol-
ume of the recovered specimen was recorded and ranged
from 8.5 to 11 ml. The aliquots of fluids were stored at
–80° C until testing.
Bacterial vaginosis was defined clinically by the pres-
ence of homogeneous nonadherent vaginal discharge,
odor in the presence of 10% potassium hydroxide, and
vaginal pH ‡ 4.7. The vaginal Gram stain was evaluated
with criteria developed by Nugent et al.15 Clue cells were
rated as >20% or <20%. The number of polymorphonu-
clear neutrophils was also recorded. Both clinical and
Gram stain criteria (score >6) were required for enroll-
ment in the group with bacterial vaginosis. Controls were
healthy subjects without vaginal symptoms and with a
score of 0 to 2 according to Nugent et al. Patients with
candidiasis were clinically evaluated, and the diagnosis
was supported by examination of Gram-stained slides.
Levels of hemolysin-specific IgA by enzyme-linked im-
munosorbent assay (ELISA). Anti–hemolysin IgA levels
were detected by ELISA with 96-well microtiter plates
(flat bottom; Costar, Cambridge, Mass.) coated with puri-
fied G. vaginalis toxin as described previously.12, 14
Briefly, vaginal washings were added to duplicate wells
and incubated at room temperature for 2 hours.
Immunoglobulins that were reactive with the toxin were
detected with alkaline phosphatase–conjugated sheep
antihuman IgA (Silenus, Miami). The optical density was
measured at 405 nm on a micro-ELISA plate reader.
Positive samples had absorbance >380 milli–optical den-
sity units (mOD) (cutoff value) after subtraction of the
background value.
Sialidase test. To quantitatively assay the vaginal wash
samples for sialidase activity, 100 m l of the specimen was
incubated on a microplate at room temperature and
placed on a shaker with 100 m l of the substrate 2-(3´-
methoxyphenyl)-N-acetyl-D-neuraminic acid (Sigma, St.
Louis) dissolved in 0.05 mol/L sodium acetate, pH 5.0.16
After 1 hour of incubation 50 m l of 4 mmol/L4-
aminoantipyrine and 50 m l of 6 mmol/L potassium ferri-
cyanide were added. A duplicate sample lacking the sub-
strate served as sample blank. Absorbances were read at
492 nm. Nonspecific absorbance as a result of the hydrol-
ysis products contaminating the substrate was subtracted
by duplicate blanks performed without vaginal washes.
Specific activity was defined as nanomoles of
methoxyphenol formed according to a standard curve
obtained with pure methoxyphenol. All assays were per-
formed in duplicate.
To determine optimal conditions for sialidase evalua-
tion, a subset of samples was preliminarily examined at a
different pH of incubation with the following buffers: 0.1
mol/L sodium lactate at pH 2.5, 3.0, 3.5, 4.0, and 4.5; 0.1
mol/L sodium acetate at pH 4.5, 5.0, and 5.5; 0.1 mol/L
phosphate buffer at pH 5.9, 6.5, 7.4, and 8.0. 
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Fig. 1. Sialidase activity in vaginal washings of 8 patients with bac-
terial vaginosis as a function of pH of incubation buffer.
Statistical analysis. We compared sialidase activity lev-
els in the bacterial vaginosis patient groups, in patients
with candidiasis, and in healthy control subjects by analy-
sis of variance, followed by the Bonferroni (modified
least-significant difference test) and Tukey-B tests as ap-
propriate. The Student t test for unpaired observations
was used to compare the differences in mean sialidase
levels between patient groups; t tests for paired samples
were used to analyze the pH within-subject effect. A two-
tailed p value < 0.05 was considered to indicate statistical
significance.
Results
A total of 222 women were screened for evaluation of
sialidase activity. Thirty-two were patients with bacterial
vaginosis showing an IgA-specific response to G. vaginalis
hemolysin (anti–G. vaginalis toxin IgA-positive sub-
group), whereas 40 patients with bacterial vaginosis had
anti–G. vaginalis toxin IgA below the cutoff value of 380
mOD (specific IgA-negative subgroup). Two control
groups were used: one of 19 patients with candidiasis
without bacterial vaginosis and one of 131 healthy sub-
jects without any vaginal infection.
Fig. 1 shows the variation in sialidase activity of the
vaginal wash taken from 8 patients as a function of the
pH value in the incubation buffer. The pH profile dif-
fered slightly in different patients, but the maximal enzy-
matic activity was always found in the pH range 4.5 to 5.5.
At higher pH values sialidase activity was significantly re-
duced. At pH 5.9 an average 30% reduction of enzymatic
activity was found. At pH 7.4 the reduction reached 90%,
with little activity still present at pH 8.0. Interestingly, low
pH values, normally found in healthy women, drastically
decrease sialidase activity. An average 80% reduction was
measured at pH 3.5, and at pH 3.0 no activity was found.
Paired t test on 67 women showed no statistical differ-
ence between sialidase activity values at pH 4.5 and 5.0 (p
= 0.225), whereas values at pH 5.9 were statistically differ-
ent from those at pH 5.0 (p < 0.001) and at pH 4.5 (p <
0.001). No variation of response was found by increasing
the incubation time with the sialic substrate up to 8
hours. pH 5.0 was chosen for evaluation of sialidase activ-
ity in vaginal washes of all the population studied.
When data for sialidase activity were examined by
analysis of variance, followed by the Bonferroni (modi-
fied least-significant difference) and Tukey-B tests as ap-
propriate, sialidase activity was highly associated with bac-
terial vaginosis (p < 0.001). No significant difference was
found between patients with candidiasis and healthy con-
trol subjects (p = 0.397). Each subgroup of patients with
bacterial vaginosis differed significantly from women
with candidiasis and from healthy control subjects (p <
0.001). Moreover, the anti–G. vaginalis IgA-positive sub-
group of patients with bacterial vaginosis differed signifi-
cantly from the anti–G. vaginalis IgA-negative subgroup
(p < 0.001). The mean value of sialidase activity in the
IgA-negative subgroup (mean ± SD, 10.07 ± 10.23 nmol
of methoxyphenol) was fivefold higher than that of the
IgA-positive subgroup (mean ± SD, 2.26 ± 3.13 nmol of
methoxyphenol). Eighteen of 72 (25%) women with bac-
terial vaginosis had no sialidase activity, 5 of 40 (12.5%)
in the IgA-negative subgroup and 13 of 32 (41%) in the
IgA-positive subgroup of women. None of the patients
with candidiasis had sialidase activity. Seven of 131 (5%)
healthy subjects had detectable sialidase levels.
If a cutoff value of 0.5 nmol of methoxyphenol is cho-
sen, which corresponds visually to a pale pink coloration
close to the detection limit in the spectrophotometric
measurement (an absorbance value of 0.048 at 492 nm),
the sensitivity of the test is 69% (50/72) for all women
having bacterial vaginosis, 85% (34/40) for the IgA-
negative subgroup and 50% (16/32) for the IgA-positive
subgroup of patients. Specificity of the test becomes 98%
(two positive results with 131 healthy controls).
Fig. 2 shows the distribution of the sialidase levels in
the four groups of women: (1) the anti–G. vaginalis toxin
IgA-positive subgroup of patients with bacterial vaginosis,
(2) the anti–G. vaginalis toxin IgA-negative subgroup of
patients with bacterial vaginosis, (3) the group of women
with candidiasis (without bacterial vaginosis), and (4) the
control group of healthy women.
Comment
Our previous detection of a specific IgA response to
the G. vaginalis hemolysin in only 55% of women with
positive cultures for G. vaginalis14 raised the question of
the mechanisms underlying the mucosal immune re-
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Fig. 2. Sialidase activity levels, measured at pH 5, in vaginal wash-
ings of four groups of women: (1) anti–G. vaginalis toxin IgA-
positive subgroup of patients with bacterial vaginosis, (2) anti–
G. vaginalis toxin IgA-negative subgroup of patients with bacter-
ial vaginosis, (3) group of women with candidiasis (without bac-
terial vaginosis), and (4) control group of healthy women.
sponse in patients with bacterial vaginosis. We have
looked for a virulence factor that differs from the G. vagi-
nalis cytolysin to substantiate the existence of differences
among patients with bacterial vaginosis. This study
demonstrates that a high level of sialidase activity is asso-
ciated with the absence of a local IgA immune response
to G. vaginalis cytolysin.
Sialidases are implicated as virulence factors in a range
of diseases such as peritonitis, septicemia, gastritis, and
periodontal and respiratory disease.17 Sialic residues oc-
cupy the terminal positions of the O-glycosidic oligosac-
charides found in mucins. Degradation of mucins pre-
sent in the mucus gel layer by microbial pathogen
enzymes is thought to be an important factor in the gen-
esis of bacterial colonization of mucosal surfaces by com-
promising local host defenses and by providing nutrients
to the invading microflora.8, 17, 18 The large number of
sugar chains in mucins are considered to have protective
functions against proteolysis of the inner core. Previous
investigations have shown that sialidase activity is de-
tectable in the vaginal fluid of patients with bacterial vagi-
nosis and that anaerobic gram-negative rods such as
Prevotella and Bacteroides spp. are the most probable
source of sialidases.9, 10 Sialidase activity was found in all
the P. bivia isolates but not in those of Mycoplasma hominis
and Mobiluncus from patients with bacterial vaginosis.
Noteworthy sialidase activity was present in washings of
all women in whom oral therapy (with metronidazole or
ampicillin) failed and in whom recurrent bacterial vagi-
nosis developed 1 month after therapy.9 Moreover, siali-
dase activity, present after topical treatment with 2% clin-
damycin, correlates with prematurity and low birth
weight,11 supporting the notion that the production of
sialidases by anaerobes is involved in the pathogenesis of
bacterial vaginosis. Our data suggest that sialidases may
promote virulence not only by destroying the mucins and
enhancing adhesion of bacteria but also by impairing the
specific IgA immune response against virulence factors
such as cytolysins. Other mechanisms such as the modifi-
cation of the carbohydrate complexes involved in cellu-
lar recognition events and in aspecific antibacterial func-
tions of secretory IgA may be compromised.19, 20 It is
tempting to speculate that G. vaginalis colonization is rel-
atively inoffensive until the host immune system is able to
counteract the cytotoxic effects of its secreted cytolysin.
This is in keeping with the observation that colonization
by G. vaginalis in patients without anaerobic overgrowth
may frequently be asymptomatic and transient. When
synergistic growth of anaerobic bacteria occurs, micro-
bial factors such as hydrolytic enzymes or exoproducts
impair the immune response of the host, permitting the
toxin to elude clearance and explicate all its virulence
potential. Synergistic mechanisms between microorgan-
isms involved in bacterial vaginosis have been hypothe-
sized in the past,21-23 and very recently a symbiotic rela-
tionship between G. vaginalis and P. bivia involving am-
monia utilization by the former was reported.24
The profile of sialidase activity as a function of pH
gives a rationale to the choice of the best conditions for
enzyme detection in the vaginal fluids of women with
bacterial vaginosis. It is of interest to note that at pH val-
ues below 4.5, which are normally found in healthy
women, sialidase activity is rapidly reduced, and at pH 3.5
most of it is lost. This observation could be of relevance
in the strategies adopted to eradicate bacterial vaginosis
by local therapy. However, it must be reemphasized that
sialidases are often one of several virulence factors se-
creted by bacteria and there are no clear examples that
inhibition of secreted bacterial sialidases would halt a dis-
ease.17
Bacterial vaginosis seems to have a multifactorial na-
ture, and it is conceivable that the factors differ among
patients leading to more or less severe outcomes. Our
data show that a considerable portion of the patients
have a high level of sialidase activity. This could impair
the immune mucosal defense by cleaving the sialic acid
residues of the IgA molecules, making them more acces-
sible to protease degradation. This mechanism would ex-
plain the correlation found between high levels of siali-
dase activity and the absence of an IgA immune
response. If future studies demonstrate that patients with
a compromised local immune response show a higher
risk of prematurity, bacterial invasion of the amniotic cav-
ity, upper genital tract infections, and bacterial vaginosis
recurrence, sialidase activity could become a valuable di-
agnostic marker for predicting the severity of the disease
and helping in the choice of treatment.
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